Winlevi
-
Sun Pharmaceuticals bags Australia approval for Winlevi
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older Sun Pharmaceutical…
Read More » -
Sun Pharma in license and supply agreement with Cosmo Pharma
Announce territory expansion for WINLEVI to include Japan, Australia, New Zealand, Brazil, Mexico and Russia Sun Pharmaceutical Industries and Cassiopea,…
Read More » -
Sun Pharma in tie-up with Cassiopea for acne drug in US and Canada
Winlevi is expected to be available in the US in the Q4 of 2021 Sun Pharmaceutical Industries and Cassiopea, a…
Read More »